Workflow
薄膜产品PVD(普陀山)
icon
Search documents
实探丨湾芯展首日,新凯来“双线并行”,16款既有设备展实力,子公司推硬核新品“补位”
Mei Ri Jing Ji Xin Wen· 2025-10-15 05:40
10月15日~17日,2025湾区半导体产业生态博览会(湾芯展)在深圳会展中心举行。今年湾芯展除设置晶圆制造、先进封装、化合物半导体、芯片设计四大 核心展区外,还设置了AI芯片与边缘计算生态、RISC-V生态、Chiplet与先进封装三个特色展区。展览面积超过6万平方米,参展企业超过600家。 每经记者|王晶 每经编辑|陈俊杰 15日上午,《每日经济新闻》记者现场看到,深圳新凯来工业机器有限公司(以下简称新凯来)是最出圈的"人气王",上午9点前公司展位便吸引了众多参 观者。作为才成立几年的公司,新凯来对外界很多人而言是相对陌生的,但只要说起它国产半导体设备厂商的身份,人们立刻了解其含金量。因为这恰恰直 击国产半导体产业链的痛点——设备是目前发展最为薄弱的环节之一。 记者从现场了解到,本次新凯来展台展出的产品与此前公司在上海半导体设备展上的一致,分为工艺装备、量检测装备两大系列16款产品。但新凯来并未展 示任何关于光刻机的设备,另据公司工作人员介绍,参展的产品均为模型,本次参展不会有新品发布。不过公司旗下子公司将陆续推新。 本次湾芯展上,新凯来展台延续了在上海半导体设备展的产品阵容。工艺装备系列包括:薄膜产品P ...
国产半导体设备突破加速 新凯来携全链条产品矩阵亮相2025湾芯展
Ju Chao Zi Xun· 2025-10-15 02:38
另一家子公司万里眼重点展出了下一代数字网络测试产品和高频高速芯片测试产品。该公司宣布,将于今日下午发布其自主研发的新一代超高速实时示波 器,标志着其在高端测试测量仪器领域迈出关键一步。 公开资料显示,新凯来虽然成立时间不长,但背景深厚。该公司成立于2022年6月,其母公司深圳市新凯来技术有限公司成立于2021年8月。通过股权穿透, 新凯来最终由深圳市国资委全资控股。这一背景为其在资本密集型、技术密集型的半导体设备领域进行长期投入提供了稳定支撑。 新凯来在短时间内展现出覆盖半导体制造近乎全流程的设备能力,其发展速度和产品化效率在业内实属罕见,充分体现了中国在提升半导体产业链自主可控 能力上的决心与投入。 值得注意的是,在本次湾芯展首日,新凯来并未展出任何光刻机相关设备。光刻机作为半导体制造中最复杂、技术壁垒最高的核心设备之一,其研发进展备 受业界关注。此举或许表明,公司当前策略集中于在沉积、刻蚀、量测等已有优势领域率先实现突破和商业化,而对于更尖端的光刻技术,仍处于攻坚或战 略筹备阶段。 10月15日,在2025湾区半导体产业生态博览会(下称"湾芯展")上,国产半导体设备领域迎来高光时刻。成立仅三年的深圳市新凯 ...
拔剑四顾心茫然
Datayes· 2025-03-27 11:09
Group 1 - The central bank has indicated a potential reduction in reserve requirements and interest rates, leading to market uncertainty and cautious trading behavior among retail investors [1] - NIO plans to issue up to 118,793,300 Class A ordinary shares to raise funds for the development of core technologies and new products in smart electric vehicles [1] - Industrial profits for large-scale enterprises in January-February decreased by 0.3% year-on-year, with manufacturing showing a notable improvement of 4.8% [3][4] Group 2 - The chemical sector has seen a collective surge, with specific stocks like Huatai reaching their daily limit [6] - Sulfuric acid prices have increased by 66% since February 7, and sulfur prices have risen by over 49% since February 3, indicating strong demand [6] - The pharmaceutical sector is experiencing positive sentiment due to rumors of policy optimization in drug procurement [5][6] Group 3 - China's crude oil demand is showing signs of recovery, with average daily imports increasing by 5.7% year-on-year [10][12] - The operating rate of private refineries has rebounded to 46.12% as of March 21, indicating a recovery in domestic oil product demand [12] - The A-share market saw a slight rebound with the Shanghai Composite Index rising by 0.15% and total market turnover reaching 12,170 billion [5][20] Group 4 - The medical and pharmaceutical sectors are leading the market, while sectors like non-ferrous metals and public utilities are experiencing declines [31][32] - The automotive and basic chemical sectors are seeing increased trading activity, with some sectors currently at historical low price-to-earnings ratios [31][32]